UroGen Pharma Ltd.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $110.7M | $172.0M | $95.0M | $55.4M | $44.4M | $52.9M | $49.7M | $101.3M |
| Accounts Receivable | $33.1M | $20.3M | $15.4M | $12.7M | $11.7M | $7.0M | — | — |
| Inventory | $16.5M | $9.2M | $5.7M | $4.3M | $4.8M | $2.0M | — | — |
| Total Current Assets | $186.0M | $276.1M | $169.2M | $128.9M | $114.4M | $115.6M | $148.6M | $102.2M |
| Property, Plant & Equipment | $637.0K | $655.0K | $689.0K | $1.3M | $2.0M | $2.0M | $977.0K | $948.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $200.5M | $285.7M | $178.3M | $135.6M | $119.7M | $122.0M | $202.4M | $103.6M |
| Liabilities | ||||||||
| Accounts Payable | $12.1M | $10.9M | $6.5M | $5.5M | $5.8M | $3.3M | $4.7M | $4.3M |
| Total Current Liabilities | $46.4M | $45.9M | $31.2M | $23.9M | $22.4M | $21.4M | $19.5M | $13.5M |
| Long-Term Debt | $122.2M | $121.7M | $98.6M | $97.5M | $0 | — | — | — |
| Total Liabilities | $305.9M | $294.5M | $243.5M | $225.0M | $111.3M | $25.7M | $22.1M | $13.5M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-959.7M | $-806.2M | $-679.3M | $-577.1M | $-467.3M | $-356.5M | $-228.0M | $-122.9M |
| Total Stockholders' Equity | $-105.5M | $-8.8M | $-65.2M | $-89.4M | $8.4M | $96.4M | $180.3M | $90.1M |